SAB Biotherapeutics reports Q1 2026 results, enrollment progress

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 9/10/2026

1. COO
2. CHWY
3. AVAV
4. NAVN
5. PLTR
6. M
7. AAPL
8. SPY
9. ASO
10. CASY

Go back to SAB Biotherapeutics reports Q1 2026 results, enrollment progress
(NASDAQ: SABS) Delayed: 3.48 --0 (-0%)
Previous Close $3.48    52 Week High $ 
Open $3.48    52 Week Low $ 
Day High $3.48    P/E N/A 
Day Low $3.48    EPS $ 
Volume 168       

(NASDAQ: SABSW) Delayed: 0.02 --0 (-0%)
Previous Close $0.02    52 Week High $ 
Open $0.02    52 Week Low $ 
Day High $0.02    P/E N/A 
Day Low $0.02    EPS $ 
Volume 168